Sodium and menopause. Dopamine D1-receptors, Na+-K+-ATPase and CD4+ in peripheral blood as markers of renal inflammation.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic concepts and animal models without original human clinical data
What was done
This narrative review summarizes literature regarding postmenopausal sodium sensitivity, focusing on how estrogen deficiency interacts with high sodium intake to trigger immune activation and renal inflammation, drawing primarily on findings from hormone-deprived rodent models.
What was found
The abstract provides no numerical findings or sample sizes. It qualitatively reports that intact female rats maintain adequate renal sodium management without immune activation when exposed to high salt load, whereas hormone-deprived rats retain sodium and display a pro-inflammatory profile. It also notes that pharmacological blood pressure lowering in this model does not eliminate observed renal damage.
Why it matters
The review highlights that blood pressure reduction alone may not resolve immune-mediated renal injury associated with salt sensitivity after menopause, emphasizing dietary sodium restriction as a distinct preventive strategy.
Limits
As a narrative review, it presents no original clinical data, quantitative effect estimates, or systematic study selection methodology. The mechanistic evidence described in the abstract relies on rodent models of hormone deprivation, which may not fully reflect human postmenopausal physiology.
Cited by
- supports As women lose estrogen in midlife, their ability to regulate sodium declines.